+
Suven Pharmaceuticals Renamed as Cohance Lifesciences
ECONOMY & POLICY

Suven Pharmaceuticals Renamed as Cohance Lifesciences

Suven Pharmaceuticals, an integrated CDMO serving customers across the globe, has rebranded as Cohance Lifesciences.

This event represents more than just a name change—it marks a bold step forward in the company’s evolution into a specialized, technology-driven global CDMO platform, purpose-built for the future of therapeutics.

The Cohance name captures the organization’s commitment to Collaborate with global innovators to Enhance their molecules and products to deliver transformative solutions to patients and consumers worldwide.

"The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world" said Cohance Executive Chairman, Vivek Sharma.

The Ministry of Corporate Affairs, Government of India (“MCA”), has approved change of name of the Company from “Suven Pharmaceuticals” to “Cohance Lifesciences”, with effect from May 7, 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.

The Company would make necessary application to the BSE and the National Stock Exchange of India Limited for effecting change of name of the Company in due course. We further inform that the Name Clause of the Memorandum of Association of the Company stands altered accordingly, and the name “Suven Pharmaceuticals” wherever it appears in the Memorandum of Association and the Articles of Association, gets replaced with the new name “Cohance Lifesciences.”

Suven Pharmaceuticals, an integrated CDMO serving customers across the globe, has rebranded as Cohance Lifesciences. This event represents more than just a name change—it marks a bold step forward in the company’s evolution into a specialized, technology-driven global CDMO platform, purpose-built for the future of therapeutics. The Cohance name captures the organization’s commitment to Collaborate with global innovators to Enhance their molecules and products to deliver transformative solutions to patients and consumers worldwide. The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world said Cohance Executive Chairman, Vivek Sharma. The Ministry of Corporate Affairs, Government of India (“MCA”), has approved change of name of the Company from “Suven Pharmaceuticals” to “Cohance Lifesciences”, with effect from May 7, 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation. The Company would make necessary application to the BSE and the National Stock Exchange of India Limited for effecting change of name of the Company in due course. We further inform that the Name Clause of the Memorandum of Association of the Company stands altered accordingly, and the name “Suven Pharmaceuticals” wherever it appears in the Memorandum of Association and the Articles of Association, gets replaced with the new name “Cohance Lifesciences.”

Next Story
Real Estate

IGBC Green Karnataka Summit 2026 Highlights State’s Green Leadership

The CII Indian Green Building Council (IGBC) hosted the first IGBC Green Karnataka Summit 2026 in Bengaluru, bringing together government leaders, urban planners, developers, architects and industry stakeholders to deliberate on “Advancing Sustainability vis-à-vis Climate Resilience in Urban Built Karnataka”.Karnataka currently has 1,539 registered green building projects accounting for a cumulative 1.13 billion sq ft of certified green building footprint, ranking third in India by number of buildings adopting IGBC Green Building Ratings. The summit reinforced a collective shift from inte..

Next Story
Infrastructure Transport

MIC Electronics Bags First PAPIS Order from RCF Kapurthala

MIC Electronics has received a Letter of Acceptance (LoA) from Rail Coach Factory (RCF), Kapurthala, for its first order in the Passenger Announcement and Passenger Information System (PAPIS) segment, marking a new addition to the company’s railway electronics portfolio.The order was awarded following successful evaluation of the company’s bid by the competent authority. MIC Electronics said the scope of work will be executed in line with the agreed rate structure, delivery schedules, inspection requirements, warranty provisions and other standard terms and conditions prescribed by RCF.Com..

Next Story
Infrastructure Urban

Prozo Opens 1.5 Lakh Sq Ft Multi-Client Fulfilment Hub

Prozo has launched its largest multi-client fulfilment hub, a 1.5 lakh sq ft enterprise-grade facility at Horizon Industrial Parks, Gurugram, Haryana, strengthening its expanding national warehousing network. The new site is Prozo’s sixth multi-client facility in Haryana and eleventh in Northern India, within a network of over 50 fulfilment centres spanning 3 million sq ft.Designed as a model warehouse for North India, the facility combines high-specification infrastructure with Prozo’s proprietary technology stack to support complex and high-volume operations for enterprise, retail and D2..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App